# AEON Biopharma, Inc. (AEON) — capital_raise/public_offering [announced]
Source: SEC API (secapi.ai) · situation sit_0e57193eca8fe7eb51d3 · retrieved 2026-08-11T15:52:20.854Z

## Overview
AEON Biopharma, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.

On July 23, 2026, AEON Biopharma, Inc. completed the partial exercise of an over-allotment option under its underwriting agreement with Lake Street Capital Markets, LLC and the underwriters. The company issued and sold 4,696,102 shares of Class A common stock for additional gross proceeds of approximately $1.5 million, resulting in net proceeds of approximately $1.4 million after deducting underwriting discounts and commissions. This followed the company's initial public offering completed on July 15, 2026.

## Terms
- Counterparty: Lake Street Capital Markets, LLC and underwriters · Deal value: $1.5M · Consideration: cash

## Key dates
- Announced 2026-07-23

## Timeline
- 2026-07-23 · 8-K (0001837607-26-000055): 8-K - AEON Biopharma, Inc. — *AEON Biopharma, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.* On July 23, 2026, AEON Biopharma, Inc. completed the partial exercise of an over-allotment option under its underwriting agreement with Lake Street Capital Markets, LLC and the underwriters. The company issued and sold 4,696,102 shares of Class A common stock for additional gross proceeds of approximately $1.5 million, resulting in net proceeds of approximately $1.4 million after deducting underwriting discounts and commissions. This followed the company's initial public offering completed on July 15, 2026.
  https://www.sec.gov/Archives/edgar/data/1837607/0001837607-26-000055.txt

## Citations
- 0001837607-26-000055 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000183760726000055